Our analysis showed that miR-27a expression in TNBC patients was higher than that in non-TNBC patients (Supplementary Fig. 5d), whereas TMEM170B levels in breast cancer patients with TNBC were lower than that in non-TNBC patients (Supplementary Fig. 5e). The gene discussed is TMEM170B; the disease is breast cancer.